Revance Therapeutics reported $1.66M in Trade Debtors for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Adamas Pharmaceuticals ADMS:US 10.05M 57K
Aerie Pharmaceuticals AERI:US $ 64.57M 5.42M
ALKERMES ALKS:US 292.67M 13.48M
Biodelivery Sciences International BDSI:US $ 57.57M 4.7M
Bristol Myers Squibb BMY:US $ 9245M 2030M
Cara Therapeutics CARA:US $ 21.05M 20.04M
Coherus Biosciences CHRS:US $ 136.35M 5.48M
Eli Lilly And LLY:US $ 7025M 122.2M
Endo International Ordinary Shares ENDP:US $ 547.09M 76.57M
Flexion Therapeutics FLXN:US $ 29.39M 5.84M
Gw Pharmaceuticals GWPH:US $ 84.95M 13.78M
Horizon Pharma HZNP:US $ 775.37M 39.94M
JAZZ PHA JAZZ:US $ 499.02M 7.64M
Neurocrine Biosciences NBIX:US $ 163.8M 5.3M
Pacira Pharmaceuticals PCRX:US $ 49.98M 18.38M
Procter & Gamble PG:US $ 5662M 937M
Revance Therapeutics RVNC:US $ 1.66M 1.02M
Supernus Pharmaceuticals SUPN:US $ 133.68M 3.6M
Teva Pharmaceutical Industries TEVA:US $ 4046M 442M
Zogenix ZGNX:US $ 9.49M 1.78M